Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a topical pharmaceutical combination of two active ingredients: heparinoid and prednisolone valerate acetate. Heparinoids are glycosaminoglycan-like compounds with anticoagulant, anti-inflammatory, and moisturizing properties, commonly used in dermatology for their ability to improve skin hydration and reduce inflammation. Prednisolone valerate acetate is a synthetic corticosteroid prodrug that is converted in the body to prednisolone, exerting potent anti-inflammatory and immunosuppressive effects by binding the glucocorticoid receptor[6][8]. The combination is typically formulated as an oil-in-water cream for topical use in dermatological conditions such as atopic dermatitis (AD) or other inflammatory skin diseases. Clinical studies have shown that combined use of a topical steroid (prednisolone valerate acetate) with a moisturizer containing heparinoid can rapidly reduce disease severity, improve quality of life, enhance skin barrier function (as measured by transepidermal water loss), and increase skin hydration without significant adverse events[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on heparinoid + prednisolone valerate acetate.